Sanofi reduces drug waste in clinical trials with Suvoda IRT

How Sanofi leveraged Suvoda IRT to improve clinical supply management

  • 25% efficiency gain within distribution picking process 
  • Optimized drug supply with reduced waste 
  • Faster study implementations 

 

Sanofi, an innovative global healthcare company, provides treatments in a wide range of complex therapeutic areas including immune-inflammatory diseases, cancers, rare diseases, multiple sclerosis, and diabetes. Sanofi partnered with Suvoda to enhance their supply chain management efficiency in their efforts to advance medications to millions of people around the world.  

With Suvoda’s purpose-built IRT platform, Sanofi was able to achieve faster study implementations, easier mid-study adaptations, and overall cost savings.